Pancreatic Cancer Research

ResearcherChulalongkorn UniversityActive in the last 2 years

Pradermchai Kongkam

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5798-9217; OpenAlex author ID A5022095006. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 3 papers

Papers 9

  1. One-year survival rate of unresectable pancreatic cancer size 4 cm or smaller treated with or without EUS-radiofrequency ablation. Co-author DOI 10.1016/j.gie.2025.06.008↗
  2. Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ductal adenocarcinoma. Co-author DOI 10.1055/a-2535-7440↗
  3. Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ductal adenocarcinoma. Co-author DOI 10.1055/a-2571-2951↗
  4. A prospective comparative trial to determine the optimal number of EUS-guided fineneedle passes for successful organoid creation in pancreatic ductal adenocarc… Co-author DOI 10.1097/eus.0000000000000098↗
  5. EUS-guided radiofrequency ablation plus chemotherapy versus chemotherapy alone for pancreatic cancer (ERAP): An observational open-label pilot study. Co-author DOI 10.1097/eus.0000000000000003↗
  6. Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review and meta-analysis. Co-author DOI 10.4103/eus-d-20-00219↗
  7. Elastography of pancreatic ductal adenocarcinoma following EUS-guided radiofrequency ablation (with video). Co-author DOI 10.1016/j.ajg.2020.04.014↗
  8. Identification of Pancreatic Cancer in Biliary Obstruction Patients by FRY Site-specific Methylation. Co-author PMID 27797266↗
  9. Pancreatic cancer in an Asian population. Co-author DOI 10.4103/2303-9027.151361↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rungsun Rerknimitr · 9 shared papers, 2015–2025 · strength 1.49
  2. Phonthep Angsuwatcharakon · 5 shared papers, 2016–2025 · strength 0.92
  3. Parit Mekaroonkamol · 4 shared papers, 2022–2025 · strength 0.87
  4. Nipan Israsena · 3 shared papers, 2024–2025 · strength 0.70
  5. Thaninee Prasoppokakorn · 3 shared papers, 2022–2025 · strength 0.66
  6. Roongruedee Chaiteerakij · 3 shared papers, 2022–2025 · strength 0.66
  7. Thanawat Luangsukrerk · 3 shared papers, 2023–2025 · strength 0.58
  8. Pinit Kullavanijaya · 3 shared papers, 2015–2025 · strength 0.42
  9. Kasenee Tiankanon · 2 shared papers, 2023–2025 · strength 0.37
  10. Dong Wan Seo · 1 shared paper, 2023 · strength 0.16
  11. Tarek Ramzi Elia Mazzawi · 1 shared paper, 2020 · strength 0.15
  12. Apiwat Mutirangura · 1 shared paper, 2016 · strength 0.06
  13. Ratakorn Srisuttee · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.